Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients.

Saved in:
Bibliographic Details
Title: Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients.
Authors: Stec M; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA. michael.e.stec@gmail.com., Anderson M; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA., Rodgers MA; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA., Fortney T; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA., Wong DK; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China., Mak LY; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China., Yuen MF; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China., Cloherty GA; Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA. Gavin.cloherty@abbott.com.
Source: Scientific reports [Sci Rep] 2025 Aug 26; Vol. 15 (1), pp. 31471. Date of Electronic Publication: 2025 Aug 26.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-2322
DOI:10.1038/s41598-025-16059-5